What are the differences between ibogaine and psilocybin as treatments?
Psilocybin has more supporting evidence and is safer than ibogaine. Ibogaine carries a real risk of serious, potentially fatal heart rhythm disturbances and has barely been properly studied in people. Considering either one? Always discuss it with a doctor first, especially if you have heart or other health conditions.
Psilocybin (a mind-altering substance found in certain mushrooms) works through a single point of action in the brain. Ibogaine (a substance from the iboga plant) acts on dozens of different points at the same time, but each time only very weakly. That makes ibogaine far harder to understand and control.
The difference is most striking when it comes to safety. Ibogaine alters the heart's electrical rhythm in a way that can lead to cardiac arrest, and several deaths have been reported as a result. At higher concentrations the substance is also harmful to nerve cells. The available literature does not show comparable heart toxicity or nerve damage with psilocybin. That makes ibogaine considerably more dangerous to use, especially outside medically supervised settings.
Psilocybin has been studied more thoroughly in people. Several studies show promising results for alcohol and tobacco addiction: cravings decrease and people stay on track for longer, particularly when therapy is included alongside the treatment. For ibogaine in opioid addiction, there is not a single solid study in people that demonstrates it works. The positive signals come from research that is difficult to control properly. Only for cocaine addiction is there one small study in people with a positive result, but that is far too little to draw any conclusions from.
In animal studies, ibogaine reduced the urge to use opiates, cocaine, amphetamines, and nicotine. That broad effect is not seen with psilocybin. Whether it works the same way in people has not yet been proven. A related substance retained the effect on cravings in animal studies without ibogaine's side effects, but studies in people had not yet been carried out.
Psilocybin does not itself cause addiction, which sets it apart from most other substances being considered for addiction treatment. This has been less thoroughly studied for ibogaine. Legally, both substances are restricted: ibogaine is completely illegal in many countries, while psilocybin is in the early stages of regulatory recognition for therapeutic use in some countries.
All claims are based on reviews and one comprehensive review of existing studies. No large combined analyses of multiple studies are included in the source list. The evidence for ibogaine in people is scarce and uncontrolled; for psilocybin there are several studies in people, but no large well-controlled trials yet.
What does ibogaine do and what is it used for?
Research shows that ibogaine reduces drug craving and withdrawal symptoms. The heart risks are serious and well documented, so always discuss it with a doctor first.
What is the difference between magnesium bisglycinate and magnesium glycinate?
Magnesium bisglycinate and magnesium glycinate are two names for the same supplement. Whether it is absorbed better than magnesium citrate is not yet clear: the studies in healthy people contradict each other, and citrate currently has the strongest evidence base.
How do you prevent and treat migraines?
For a mild attack, start with ibuprofen or paracetamol; for severe attacks, choose a triptan as early as possible in the attack.
Is berberine safe to use if you are taking medication?
Berberine can influence the blood levels of certain medications, although the clinical significance is unclear in most cases. If you are taking medication, discuss this with your doctor or pharmacist before using berberine.
Is it better to take ashwagandha in the morning or in the evening?
More important than the timing: several regulators, including the RIVM, advise against ashwagandha because of risks to the liver, thyroid and hormones. Morning versus evening has never been studied; choose the moment you can stick to.
Does rapamycin help people live longer in good health?
Rapamycin works in mice, but whether it also leads to a longer and healthier life in humans has not yet been demonstrated. Side effects are real, long-term data in healthy people are absent, and use outside a clinical context cannot currently be justified.